| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Polaris Management Co. VII, L.l.c. last filed a Form 4 in September 2025, as 10% Owner at CAMP. The filings on record cover 2 companies.
At the last filing, the largest reported position was 197,661 shares of CAMP. Net of sales, the CAMP filings show accumulation of 2,216,279 shares.
Polaris Management Co. VII, L.l.c. has 3 Form 4 filings on record from July 2016 to September 2025, across 2 companies: 10% Owner at Camp4 Therapeutics (CAMP), 2024–2025; 10% Owner at Syros Pharmaceuticals (SYRS), 2016.
The 11 reported transactions were 6 conversions and 5 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $17.0M and no sales.
The largest open-market purchase was 909,090 shares of CAMP at an average $11.00 on October 15, 2024, about $10.0M. Twelve months later CAMP was down 68%.
Shares as reported in the last Form 4 for each company; the most recent is from September 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 1,307,189 | $1.53 | $1,999,999.17 | -117.8% | +105.8% | +52.9% | |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | New | -63.3% | -68.0% | |
| Jul 6, 2016 | SYRS Syros Pharmaceuticals, Inc. | 10% Owner | Buy | 400,000 | $12.50 | $5,000,000.00 | -113.7% | - | - |